Advertisement
Screener

NovoCure Limited (NVCR) Graph

NVCR Revenue Flow

Filed revenue amounts for 2026-04-01 to 2026-06-30. Coverage is partial. Unconnected amounts are separate disclosures; they must not be added together.

  • 2026-06-30: Revenue $183.58M; Cost of revenue $41.11M; Research and development $51.45M; Operating expenses $153.04M.
  • 2026-03-31: Revenue $174.06M; Cost of revenue $38.93M; Research and development $58.34M; Operating expenses $202.55M.
  • 2025-09-30: Revenue $167.20M; Cost of revenue $44.73M; Research and development $54.03M; Operating expenses $158.50M.
  • 2025-06-30: Revenue $158.81M; Cost of revenue $41.47M; Research and development $55.83M; Operating expenses $156.85M.

Geography

Separate filed amounts; connecting flows are not established. Components and totals may overlap.

NVCR revenue flowFiled amounts. Only explicit calculation relationships connect amounts; dimensional membership alone does not establish an additive flow.International Markets$74.67MOther InternationalMarkets$18.20MCN$5.96MDE$23.34MFR$21.35MJP$11.78MUS$102.96MRevenue$183.58MCost of revenue$41.11MGross profit$142.48MOperating expenses$153.04MOperating income-$10.56MResearch & development$51.45MPre-tax income-$12.45MIncome tax$3.21MNet income-$15.66M

Revenue Performance Obligation Period Obligation Was Satisfied In

Separate filed amounts; connecting flows are not established. Components and totals may overlap.

NVCR revenue flowFiled amounts. Only explicit calculation relationships connect amounts; dimensional membership alone does not establish an additive flow.Previous Periods$8.77MReporting Period$174.81MRevenue$183.58MCost of revenue$41.11MGross profit$142.48MOperating expenses$153.04MOperating income-$10.56MResearch & development$51.45MPre-tax income-$12.45MIncome tax$3.21MNet income-$15.66M

Finer product or service dollar figures and nonoverlapping groupings are shown only where supported by the retained filing evidence. Growth percentages are never converted to revenue dollars.

Historical revenue and expense breakdown

Revenue and expense 3 month

Period endRevenueCost of revenueResearch and developmentOperating expensesIncome taxNet income
2026-06-30$183.58M$41.11M$51.45M$153.04M$3.21M-$15.66M
2026-03-31$174.06M$38.93M$58.34M$202.55M$1.88M-$71.14M
2025-09-30$167.20M$44.73M$54.03M$158.50M$7.25M-$37.27M
2025-06-30$158.81M$41.47M$55.83M$156.85M$5.16M-$40.14M
2025-03-31$154.99M$38.52M$53.78M$154.34M$4.02M-$34.32M
2024-09-30$155.09M$35.37M$51.88M$151.81M$8.98M-$30.57M
2024-06-30$150.36M$34.65M$54.95M$149.28M$10.65M-$33.38M
2024-03-31$138.50M$33.69M$51.60M$146.33M$7.12M-$38.76M
2023-09-30$127.32M$32.09M$53.62M$153.47M$1.26M-$49.48M
2023-06-30$126.05M$34.02M$55.43M$154.69M$3.51M-$57.42M
2023-03-31$122.18M$29.61M$59.70M$152.82M$1.98M-$53.06M
2022-12-31$128.43M(m)(m)(m)(m)-$37.30M
2022-09-30$131.00M$29.75M$51.96M$125.86M$3.16M-$26.58M
2022-06-30$140.87M$28.50M$57.08M$133.49M$652.00K-$24.01M
2022-03-31$137.55M$27.73M$42.23M$110.63M$2.13M-$4.65M
2021-12-31$133.21M(m)(m)(m)(m)-$26.46M
2021-09-30$133.61M$30.21M$48.14M$111.95M$2.59M-$13.12M
2021-06-30$133.52M$28.60M$50.31M$117.21M$1.41M-$14.64M
2021-03-31$134.69M$26.39M$45.92M$108.40M$1.39M-$4.13M
2020-12-31$143.95M(m)(m)(m)(m)$4.92M
2020-09-30$132.66M$28.39M$32.82M$89.24M$1.75M$9.28M
2020-06-30$115.92M$25.47M$29.92M$83.78M$2.40M$1.66M
2020-03-31$101.83M$24.50M$25.27M$80.71M-$9.77M$3.95M
2019-12-31$99.23M(m)(m)(m)(m)$4.26M
2019-09-30$92.06M$22.90M$18.77M$65.31M-$630.00K$1.93M
2019-06-30$86.71M$21.11M$19.45M$64.41M$1.23M-$1.27M
2019-03-31$73.31M$19.81M$17.04M$59.61M$3.66M-$12.15M
2018-12-31$69.67M(m)(m)(m)(m)-$15.63M
2018-09-30$64.76M$18.95M$13.07M$51.05M$4.05M-$11.69M
2018-06-30$61.51M$19.83M$11.36M$48.77M$5.57M-$15.51M
2018-03-31$52.13M$18.24M$11.10M$46.56M$3.19M-$20.72M
2017-12-31$53.66M(m)(m)(m)(m)-$10.95M
2017-09-30$50.11M$15.15M$9.27M$40.88M$3.42M-$11.50M
2017-06-30$38.38M$13.15M$9.37M$40.75M$3.46M-$21.17M
2017-03-31$34.88M$11.66M$9.41M$36.59M$2.23M-$18.05M
2016-12-31$30.24M(m)(m)(m)(m)-$22.17M
2016-09-30$21.67M$11.12M$10.23M$38.82M$3.17M-$33.63M
2016-06-30$17.92M$9.80M$11.32M$38.95M$2.82M-$40.61M
2016-03-31$13.05M$7.98M$11.45M$37.01M$2.95M-$35.44M
2015-12-31$12.38M(m)(m)(m)(m)-$32.93M
2015-09-30$8.95M$5.66M$10.21M$27.53M$976.00K-$26.02M
2015-06-30$6.54M$4.75M$12.77M$29.00M$1.27M-$29.36M
2015-03-31$5.21M$3.90M$9.93M$23.26M$736.00K-$23.27M
2014-09-30$4.37M$2.59M$9.28M$19.69M$362.00K-$18.32M

Revenue and expense 6 month

Period endRevenueCost of revenueResearch and developmentOperating expensesIncome taxNet income
2026-06-30$357.64M$80.03M$109.78M$355.59M$5.09M-$86.80M
2025-06-30$313.80M$79.99M$109.61M$311.19M$9.18M-$74.46M
2024-06-30$288.86M$68.34M$106.55M$295.62M$17.76M-$72.14M
2023-06-30$248.23M$63.63M$115.13M$307.51M$5.50M-$110.48M
2022-06-30$278.41M$56.23M$99.31M$244.12M$2.78M-$28.66M
2021-06-30$268.21M$54.98M$96.23M$225.61M$2.80M-$18.77M
2020-06-30$217.75M$49.97M$55.19M$164.50M-$7.37M$5.61M
2019-06-30$160.02M$40.92M$36.50M$124.02M$4.89M-$13.42M
2018-06-30$113.64M$38.07M$22.47M$95.33M$8.76M-$36.23M
2017-06-30$73.26M$24.82M$18.78M$77.34M$5.69M-$39.22M
2016-06-30$30.97M$17.78M$22.76M$75.96M$5.77M-$76.05M
2015-06-30$11.75M$8.65M$22.69M$52.26M$2.01M-$52.63M

Revenue and expense 9 month

Period endRevenueCost of revenueResearch and developmentOperating expensesIncome taxNet income
2025-09-30$481.00M$124.72M$163.64M$469.69M$16.43M-$111.73M
2024-09-30$443.95M$103.72M$158.44M$447.43M$26.75M-$102.70M
2023-09-30$375.55M$95.72M$168.75M$460.98M$6.76M-$159.96M
2022-09-30$409.41M$85.98M$151.26M$369.98M$5.94M-$55.23M
2021-09-30$401.82M$85.19M$144.37M$337.56M$5.39M-$31.89M
2020-09-30$350.41M$78.36M$88.01M$253.74M-$5.61M$14.89M
2019-09-30$252.08M$63.82M$55.26M$189.33M$4.26M-$11.49M
2018-09-30$178.40M$57.02M$35.54M$146.38M$12.81M-$47.93M
2017-09-30$123.36M$39.97M$28.05M$118.22M$9.11M-$50.72M
2016-09-30$52.65M$28.90M$33.00M$114.78M$8.94M-$109.68M
2015-09-30$20.70M$14.31M$32.90M$79.79M$2.99M-$78.65M
2014-09-30$11.69M$7.41M$29.19M$61.43M$528.00K-$57.77M

Revenue and expense 12 month

Period endRevenueCost of revenueResearch and developmentOperating expensesIncome taxNet income
2025-12-31$655.35M$166.88M$224.54M$642.27M-$23.00K-$136.23M
2024-12-31$605.22M$137.18M$209.65M$638.53M$37.47M-$169.00M
2023-12-31$509.34M$128.28M$223.06M$613.93M$15.30M-$207.00M
2022-12-31$537.84M$114.87M$206.09M$512.50M$10.69M-$93.00M
2021-12-31$535.03M$114.88M$201.30M$464.49M$6.28M-$58.00M
2020-12-31$494.37M$106.50M$132.01M$357.46M-$1.71M$19.81M
2019-12-31$351.32M$88.61M$79.00M$263.63M-$1.59M-$7.23M
2018-12-31$248.07M$80.05M$50.57M$201.69M$17.62M-$63.56M
2017-12-31$177.03M$55.61M$38.10M$160.75M$13.16M-$61.66M
2016-12-31$82.89M$39.87M$41.47M$151.92M$10.38M-$131.84M
2015-12-31$33.09M$20.61M$43.75M$116.47M$4.43M-$111.58M
2014-12-31$15.49M$10.04M$40.38M$85.61M$382.00K-$80.68M
2013-12-31$10.36M$7.01M$34.80M$67.81M$353.00K-$77.37M

Similar stocks

Stock NameCountryMarket CapPE Ratio
LEMAITRE VASCULAR INC (LMAT)United States$1.848B33.37
Inspire Medical Systems, Inc. (INSP)United States$1.990B9.55
KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS)United States$1.535B-9.02
Alphatec Holdings, Inc. (ATEC)United States$1.531B-12.14
UFP TECHNOLOGIES INC (UFPT)United States$2.308B28.37
INTEGRA LIFESCIENCES HOLDINGS CORP (IART)United States$1.234B-193.02
ARTIVION, INC. (AORT)United States$1.123B-345.09
IRADIMED CORP (IRMD)United States$1.089B52.92
TANDEM DIABETES CARE INC (TNDM)United States$1.059B-16.57
PROCEPT BioRobotics Corp (PRCT)United States$1.001B-11.77